Connect with us

Cannabis News

Massachusetts Governor Signs Bill Doubling Legal Marijuana Possession Limit And Revising Industry Rules

Published

on

The governor of Massachusetts has signed a bill double the legal limit for adult marijuana possession and revise the regulatory framework for the state’s adult cannabis market.

Gov. Maura Healey (D) approved the legislation Sunday, about a week and a half after lawmakers sent it to her desk in unanimous House and Senate votes.

“The cannabis industry is an important part of the Massachusetts economy: it supports jobs and local businesses and generates revenue for cities and towns,” Healey said in a press release. “It is important that we are doing everything we can to ensure that this industry is set up to succeed and remain competitive in this growing market. I am grateful to the Legislature for their leadership on this critical reform project.”

A bicameral conference committee spent months working on provisions of the legislation after the two chambers passed different versions last year, and the committee approved the compromise approach on Monday.

“With the governor’s signature today, our legislature takes an important step toward making the cannabis industry here in Massachusetts more profitable, profitable and competitive for business owners and consumers,” said Sen. Adam Gómez (D), who chaired the bicameral panel. “This legislation strengthens the Cannabis Regulatory Commission’s oversight by making smart updates that help small businesses, improve accountability, and ensure consumers can safely and legally access cannabis.”

“By clarifying shipping and advertising rules, increasing accounts receivable transparency, increasing purchase amounts and modernizing licensing limits, we’re building a more stable and fairer cannabis market for our state and I’m proud of our body for prioritizing reform this session,” he said.

Rep. Daniel M. Donahue (D), who also chaired the conference committee and co-chairs the Joint Committee on Cannabis Policy with Gómez, said he is “delighted” that the legislation became law.

“These reforms represent a new commitment to ensuring a safe, equitable and prosperous future for the Commonwealth’s legalized cannabis industry,” he said. “I look forward to working with the administration through their implementation.”

Among the revisions to the state’s cannabis law is a section that increases the personal possession limit of marijuana from one ounce to two. Colorado enacted the same reform in 2021 after the state’s cannabis market matured.

H.5350 reduces the size of the Cannabis Control Commission (CCC) and overhauls the organization, while also updating the limits on marijuana business licenses.


It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.


Learn more about our marijuana bill tracking and become a Patreon supporter to gain access

According to the versions of both chambers invoiceThe CCC would consist of three members instead of the current five. Conference committee the report it takes provisions of the House measure that has now become law that would allow the governor to make all appointments, with the Senate approach giving the attorney general one of the appointments. According to the previous law, the treasurer also had a role in appointing committee members, but this will no longer be the case.

The proposal calls for one member of the CCC to have a background in social justice, while the other two commissioners have a background in public health, public safety, social justice, consumer regulation or the production and distribution of cannabis.

The new law also increases the number of licenses a single entity can hold from three to six, and also raises from 10 percent to 20 percent the threshold for how much of a company’s equity is considered property to count toward the license cap. It also removes a current requirement that medical cannabis operators be vertically integrated to simultaneously cultivate, manufacture and sell marijuana.

It also empowers regulators to choose dispensaries to advertise sales, discounts and customer loyalty programs at retail locations and via email, and specifies that marijuana dispensary operators can deliver to any municipality unless local officials proactively ban cannabis businesses and stop delivery.

The measure creates a new portal for reporting illegal behavior and directs regulators to create a list of cannabis companies that have not paid their debts to other operators for more than 60 days and prevents regulators from doing business with other operators until the debts are settled.

The legislation also requires regulators to study and report on hemp-derived products, the public health impacts of cannabis, tax policy and workplace safety regulations.

Before the governor signed the bill, the CCC published guidance on the immediate effect of the new law.

After signing the bill on Sunday, CCC Executive Director Travis Ahern he said “During this transition, the organization will remain focused on its primary mission of regulating a safe and fair cannabis industry for Massachusetts consumers, patients, employers and taxpayers.”

Cannabis regulation reform has come into effect after state marijuana businesses filed a lawsuit aimed at blocking it. initiative to roll back the legalization law approved by state voters from reaching the November vote.

If approved, the state would not return to general prohibition; rather, it would repeal the commercial recreational sales and home cultivation components of the law, while allowing adults 21 and older to possess one ounce of cannabis for personal use.

Possession of more than one ounce but less than two ounces would effectively be decriminalized, with violators facing a $100 fine. Adults can also continue to gift cannabis to each other without payment. The sale of medical marijuana would be legal.

The measure is before the legislature after supporters provided an initial round of signatures last year, and lawmakers have until May 5 to act on the proposal. If they decide not to pass it in the legislature, the campaign would have to go through another round of petitions and get at least 12,429 certified signatures by July 1 to get on the November ballot.

The promoters faced skeptical questions from lawmakers at a hearing of the Joint Committee on Initiative Petitions last month, with several. raising concerns about the motivations behind the anti-marijuana measure and the consequences for consumers and companies.

A Bay State Poll by the University of Hampshire State Opinion Project found that A majority of Massachusetts adults oppose the initiative to repeal the sale and cultivation of marijuana.

Meanwhile, in November, the legislature’s Joint Committee on Cannabis Policy advanced a bill that would have required a study. legal barriers facing first responders who want to use marijuana in compliance with state law.

Regulators should also examine marijuana’s effectiveness in the treatment of anxiety, depression and post-traumatic stress disorder (PTSD). In addition, police and first responders in other jurisdictions will review laws and policies regarding the use of cannabis and “any other matter deemed relevant by the commission.”

The bill was reported when lawmakers in another committee passed separate legislation employment protection for people who use marijuana. Another panel advanced a a bill similar to the employment protections for cannabis in September

Meanwhile, the head of Massachusetts’ marijuana regulatory agency recently suggested measures to effectively recriminalize the sale of recreational cannabis. dangerous tax revenues being used to support substance abuse treatment efforts and other public programs.

To that point, Massachusetts recently achieved another marijuana milestone, officials announced in February that the state has. Over $9 billion in adult cannabis purchases since market launch in 2018.

A report by the Cannabis Control Commission (CCC) found that legalization is achieving one of its main goals: stopping the illegal sale of cannabis as adults move into the regulated market. It shows that among adults who used marijuana in the past year, a staggering 84 percent said they got their cannabis from a licensed source.

Massachusetts lawmakers recently joined a bicameral conference committee to hammer out a deal. double the legal limit for possession of marijuana for adults and reviewing the regulatory framework for the state’s adult cannabis market.

In December, state regulators, too established rules for the halls of social consumption of marijuana.

CCC has recently launched a targeted online platform helping people find work, on-the-job training and networking opportunities in the state’s legal cannabis industry.

Separately, members of parliament are advancing the legislation establishing pilot programs for the regulated therapeutic use of psychedelics.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Cannabis News

Aurora Cannabis announces full results for 2026 fiscal year

Published

on

By

Aurora Cannabis Inc., a Canadian medical cannabis company, released its financial results for the fourth quarter and full year 2026 (ended March 31, 2026).

CEO Miguel Martin said the company achieved record results in fiscal 2026, saw strong global growth in medical cannabis revenue and met profit targets. This success was attributed to the company’s regulatory expertise, network of EU certified production facilities and ability to execute business plans. Aurora plans to continue growing internationally while maintaining its market position.

Note: On February 17, 2026, Aurora sold its majority stake in a plant company called Bevo Agtech. Because of this sale, Bevo’s numbers are not included in the results, and the previous year’s data has been adjusted.

Total revenue for the quarter was $84.8 million, up 10% from $76.8 million a year earlier. This growth was primarily due to a 14% increase in medical cannabis sales and increased wholesale sales, although this was partially offset by lower sales of consumer cannabis.

Medical cannabis revenue reached $77.1 million (up 14%, 91% of revenue). This growth was driven by strong sales in Germany and Poland, and increased sales to insured patients in Canada. However, medical cannabis profit margins fell from 71% to 66% due to selling more low-margin products and price cuts.

Consumer cannabis revenue fell to $3.6 billion from $8.2 billion, as the company is deliberately shrinking this part of the business to focus on medical cannabis. Here, too, profit margins fell, from 27% to 22%, due to higher costs.

Overall, the company’s adjusted gross profit margin (a measure of profitability before certain accounting adjustments) was 60%, up from 65% a year ago.

Operating costs (adjusted GEA) increased to $40.3 million from $35.4 million due to additional employees, higher labor costs in Europe and Australia, bad debt from two bankrupt clients and extraordinary professional fees.

The company reported a net loss of $27.6 million for the quarter, higher than last year’s loss of $12.1 million, mainly due to one-time charges. However, “adjusted net income,” a measure that strips out unusual items, was $5.6 million, down from $15.3 million, due to higher costs and lower currency gains.

Adjusted EBITDA (a measure of profitability) was $9.2 million, down from $14.1 million. Free cash flow was just $0.3 million, down from $5.2 million.

Aurora completed the sale of its stake in Bevo (the plant breeding business) on February 17, 2026. Separately, on April 15, 2026, Aurora acquired Safari Flower Company for $26.5 million, consisting of $15 million in cash plus stock, and acquired a large certified cultivation facility to support international supply.

By 2027, Aurora will exit the low-margin Canadian cannabis and plant breeding businesses to focus on global medical cannabis. The company expects total revenue to decline, approaching 2025 levels, primarily due to lower medical reimbursement rates in Canada starting in April 2026, although this will be partially offset in Europe, particularly Germany and Poland. Gross profit margins are expected to be in the mid to high 50% range, supported by stronger contributions from Europe and exits from low-margin businesses, although medical margins in Canada remain under pressure. Operating costs are expected to be similar to last year. Overall, annualized profit as measured by adjusted EBITDA is expected to be lower than in fiscal year 2026, reflecting the impact of lower reimbursement prices on revenue and gross profit.

A conference call to discuss these results was scheduled for June 11, 2026.

For more information:
Aurora Cannabis Inc.
auroramj.com

Continue Reading

Cannabis News

More Than 100 Alabama Patients Bought Medical Marijuana In First Week Of Legal Sales

Published

on

By

“Our store manager saw a patient coming out, and as silly as it sounds, they jumped up and hit their heels. Yes, they were very happy to have that medicine.”

By Anna Barrett, Alabama Reflector

More than 100 qualifying patients have it purchased medical cannabis since the opening of Alabama’s first dispensaryThe Alabama Medical Cannabis Board said Thursday.

The state’s first purveyor of medical cannabis, Callie’s Apothecary, opened its first location in Montgomery on June 4 after a “soft opening” the day before. Justin Aday, the commission’s general counsel, said Thursday that 102 patients have purchased medical cannabis products in 111 transactions. Those transactions generated about $14,600 in pretax sales, with the average transaction being $131.56, Aday said.

Vince Schilleci, owner of Callie’s, said in a phone interview Thursday afternoon that the last week of business has been rewarding.

“I’m seeing a lot of happy patients,” he said. “Our store manager saw a patient coming out, and as silly as it sounds, they jumped up and hit their heels. Yes, they were very happy to have that medicine.”

According to the patient menu on Callie’s website, each item ranges from $42 to $52. Schilleci said the dispensary got its second shipment of products on Thursday and expects another on Friday, which will help meet patient demand.

“We had to, I hate to use this term ration, but we limited how much patients could buy because we knew how many patients were coming in, and we wanted people to at least have a chance to have something,” Schilleci said. “We’ve removed rationing now so patients can go down and buy their full 60-day allotment if they want.”

Aday said that since Thursday morning, 481 patients have applied for a cannabis card, of which 446 have been issued by AMCC.

Alabama’s cannabis law, passed in 2021, allows registered doctors to prescribe cannabis for about 15 medical conditions, including cancer, depression, Parkinson’s disease, PTSD, sickle cell anemia, chronic pain and terminal illnesses. Acceptable product forms are limited to pills, tinctures, patches, oils and gel cubes (peach flavor only), plant raw and smoking forms are prohibited.

As of Thursday, there are 52 doctors in Alabama certified to recommend medical cannabis to patients, according to the Alabama Board of Medical Examiners. Aday said 39 are registered with the AMCC, three are pending, and 21 of the doctors have prescribed medicinal cannabis to their patients.

“We certainly hope to see more of these patients come to that dispensary and other dispensaries open that will provide more geographic coverage,” Aday said. “We’re working with the lab processors on the new products that are being manufactured so that the dispensary has an inventory of the products and various products in that inventory to serve the patients that are visiting.”

Lawsuits have also hindered access to medical cannabis. Some companies sued the commission for not issuing licenses, citing a discriminatory process. In another case five parents sued the board over delays in accessing cannabis, which was dismissed in August.

Licenses for three of the four potential dispensary companies were not approved until December.

Three of the companies, CCS of Alabama, LLC, GP6 Wellness, LLC and RJK Holdings, LLC, have licenses and are expected to open storefronts this summer, according to AMCC Director John McMillan. A fourth license is pending litigation, but is likely to go to Yellowhammer Medical Dispensaries, LLC.

“I would do it all over again to see the smile on these patients’ faces. Now, I would have expected it to be a little easier, but it was worth it,” Schilleci said. “It’s been worth it. There’s no doubt about it.”

This story was first published by the Alabama Reflector.

user photo Max Pixel.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

Columbia hemp business Burning Acre to close and move to North Carolina over new Tennessee rules

Published

on

By











Burning Acre, a Columbia, Tennessee-based hemp company, says it will close its retail store and move operations to North Carolina ahead of new state regulations that take effect July 1, according to WSMV.

The business says its last day to open in Columbia will be June 30, the same day the Tennessee Department of Agriculture licenses for hemp-derived cannabinoids expire. As of July 1, businesses that continue to operate in the state will be required to be licensed under a new regulatory framework led by the Tennessee Alcoholic Beverage Commission.

Burning Acre says the changes have forced it to abandon plans for a new sandwich shop and bakery and close its Tennessee retail operations and relocate to Murphy, North Carolina. “I won’t sugarcoat it, it’s a very hard video for me and a message I should never have written,” the business wrote.

The business puts the annual cost of manufacturing, distribution and running the retail store at about $750. Under the new rules, he says, those costs would rise by tens of thousands of dollars, citing new licensing fees, a required $25,000 annual bond and increased testing fees.

The law, which took effect in July, changes the regulation of hemp-derived cannabinoid businesses from the Department of Agriculture to the ABC. The Department of Agriculture stopped issuing licenses at the end of 2025, and the licenses issued by the TDA will remain valid until June 30, 2026.

“Columbia, we absolutely love being a part of this community,” said Burning Acre. “We are truly heartbroken to have to say goodbye to this location.”

Read more at WSMV4










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media